Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 19;7(3):120. doi: 10.3390/vaccines7030120

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Correlation between peripheral blood monocyte counts before and within 24 h after administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) (75 μg filgrastim). (a) The peripheral blood monocyte counts before and 16–18 h after administration of rhG-CSF were 410 ± 195/μL and 586 ± 238/μL (n = 40), respectively, indicating a 1.5-fold increase. (b) CD34⁺ stem cells did not increase 24 h after rhG-CSF administration (before, 0.401 ± 0.273/µL; after 0.169 ± 0.056/µL (n = 20).